DNA修復薬の世界市場 (薬剤の種類別、剤形別、作用機序別、用途別、流通チャネル別)：将来予測 (2025～2030年)

DNA修復薬市場は、2023年に85億8,000万米ドルと評価され、2024年には91億8,000万米ドルに達すると予測され、CAGR 7.20％で成長し、2030年には139億7,000万米ドルに達すると予測されています。

DNA修復薬市場は主に、さまざまな遺伝性疾患やがんを治療するために損傷したDNAを修復することを目的とした治療薬の開発と商業化に関わる。このような薬剤の必要性は、環境要因やライフスタイルの変化に起因することが多いがんや遺伝子変異の有病率の増加によってもたらされています。DNA修復薬は、細胞の正常な機能を回復させるために主に腫瘍学に応用され、乳がん、卵巣がん、前立腺がん、といったがんの治療に不可欠です。最終用途の範囲には、病院、専門クリニック、研究機関が含まれ、治療的介入を進めることに重点を置いています。成長に影響を与える主な要因としては、製薬企業による研究開発投資の増加、遺伝子疾患に対する理解の深まり、精密医療を可能にする技術の進歩などが挙げられます。個別化医療への注目の高まりは、個人の遺伝子情報を活用することでオーダーメイドの治療が可能になり、患者の転帰を改善できるため、大きなビジネスチャンスとなります。しかし、市場開拓は、高い開発コストや規制当局の承認プロセスの長さといった限界に直面しています。また、潜在的な副作用や遺伝子組み換えに関する倫理的懸念といった課題もあります。

とはいえ、潜在的なチャンスはいくつかあります。企業は、バイオテクノロジー企業との提携を検討し、専門知識を組み合わせることで、イノベーションと製品開発を迅速に進めることができると思われます。CRISPRやAIを活用した創薬のような最先端技術への投資は、より精度の高い治療法の開発につながり、競争力をもたらす可能性があります。免疫療法や標的療法にDNA修復薬を組み込んだ併用療法の調査により、治療の可能性が広がる可能性があります。イノベーションは、副作用を最小限に抑えながら薬剤の有効性を高めることに焦点を当てるべきであり、薬剤が利用しやすく費用対効果の高いものであることを保証するものです。市場は本質的に日進月歩であるため、俊敏性を維持することが重要です。企業は、市場の変化を利用するために、規制ガイドラインや新たな動向について常に最新情報を入手しておく必要があります。

市場力学：急速に進化するDNA修復薬市場の主要市場インサイトを公開

DNA修復薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患および遺伝性疾患の世界の増加
  • 開発のための臨床試験や研究開発の拡大
  • 複雑な疾患の治療へのアクセスを促進する政府の取り組み
• 市場抑制要因
  • 製剤上の問題とDNA修復薬の複雑さ
• 市場機会
  • DNA修復薬の有効性と安全性を向上させるための継続的な技術革新
  • 複雑な疾患を管理するための個別化・精密化戦略に対する消費者の嗜好
• 市場の課題
  • 有効性と安全性の懸念に伴う限界

ポーターのファイブフォース：DNA修復薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：DNA修復薬市場における外部からの影響の把握

外部マクロ環境要因は、DNA修復薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：DNA修復薬市場における競合情勢の把握

DNA修復薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：DNA修復薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、DNA修復薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：DNA修復薬市場における成功への道筋を描く

DNA修復薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

当レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1. 市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2. 市場の発展度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3. 市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4. 競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5. 製品開発・イノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1. 現在の市場規模と今後の成長予測は？

2. 最高の投資機会を提供する製品、セグメント、地域はどこか？

3. 市場を形成する主な技術動向と規制の影響とは？

4. 主要ベンダーの市場シェアと競合ポジションは？

5. ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序論

第2章 分析手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患や遺伝性疾患の発生率が増加
    • 臨床試験と調査イニシアチブを拡大し、DNA修復薬を開発する
    • 複雑な病気の治療へのアクセスを促進する政府の取り組み
  • 抑制要因
    • DNA修復薬の定式化の問題と複雑さ
  • 機会
    • DNA修復薬の有効性と安全性を向上させるための継続的なイノベーション
    • 複雑な疾患を管理するための個別化された精密な戦略に対する消費者の好み
  • 課題
    • 有効性と安全性に関する懸念に関連する制限
• 市場セグメンテーション分析
  • 剤形：薬剤を迅速に投与するための注射剤の大幅な導入
  • 用途：腫瘍学における標的ドラッグデリバリーにおけるDNA修復薬物療法の応用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的要因
  • 経済的要因
  • 社会的要因
  • 技術的要因
  • 法的要因
  • 環境的要因

第6章 DNA修復薬市場：薬剤の種類別

• アルキル化剤
• ポリADPリボースポリメラーゼ阻害剤

第7章 DNA修復薬の市場：形状別

• カプセル
• 注射剤
• タブレット

第8章 DNA修復薬市場：作用機序別

• 塩基除去修復調節因子
• 二本鎖切断修復調節因子
• ミスマッチ修復調整因子
• 一本鎖切断修復調節因子

第9章 DNA修復薬の市場：用途別

• 神経疾患
• 腫瘍
  • 乳がん
  • 卵巣がん
  • 前立腺がん

第10章 DNA修復薬の市場：流通チャネル別

• 病院薬局
• オンライン薬局

第11章 南北アメリカのDNA修復薬の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のDNA修復薬の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのDNA修復薬の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析 (2023年)
• FPNVポジショニングマトリックス (2023年)
• 競合シナリオ分析
  • メルクKGaAと江蘇省恒瑞製薬株式会社ががん治療の革新に向けて提携
  • F. Hoffmann-La Roche AGとKSQ Therapeutics, Inc.によるがん治療におけるコラボレーションとイノベーションDNA修復薬
  • FDA、遺伝子変異を伴う進行性前立腺がんに対する新たな併用療法を承認
• 戦略分析と提言

企業一覧

• Artios Pharma
• AstraZeneca PLC
• Aurigene Discovery Technologies
• Bio-Rad Laboratories, Inc.
• Bristol-Myers Squibb Company
• CanBas Co., Ltd.
• Clovis Oncology
• Corden Pharma International GmbH
• Eli Lilly and Company
• Genentech, Inc.
• GlaxoSmithKline PLC
• Hanson Wade Group
• Johnson & Johnson Services, Inc.
• Merck KgaA
• Novartis AG
• Pfizer Inc.
• Valerio Therapeutics

LIST OF FIGURES

• FIGURE 1. DNA REPAIR DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. DNA REPAIR DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DNA REPAIR DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DNA REPAIR DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY POLY ADP RIBOSE POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BASE EXCISION REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DOUBLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MISMATCH REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY SINGLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 50. CANADA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CANADA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 82. CHINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. CHINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 88. INDIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 89. INDIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. INDIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ITALY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 191. ITALY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 192. ITALY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ITALY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 214. POLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 215. POLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 216. POLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. POLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 220. QATAR DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 221. QATAR DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 222. QATAR DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. QATAR DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 279. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 280. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

The DNA Repair Drugs Market was valued at USD 8.58 billion in 2023, expected to reach USD 9.18 billion in 2024, and is projected to grow at a CAGR of 7.20%, to USD 13.97 billion by 2030.

The DNA repair drugs market primarily involves the development and commercialization of therapeutics aimed at repairing damaged DNA to treat various genetic disorders and cancers. The necessity for these drugs is driven by the increasing prevalence of cancer and genetic mutations, often stemming from environmental factors and lifestyle changes. DNA repair drugs find application primarily in oncology to restore the normal functioning of cells and are integral in treating cancers such as breast, ovarian, and prostate cancer. The end-use scope encompasses hospitals, specialized clinics, and research institutes that focus on advancing therapeutic interventions. Key influencing growth factors include the rising investments in R&D by pharmaceuticals, an increasing understanding of genetic disorders, and advancements in technology enabling precision medicine. The burgeoning focus on personalized medicine presents a significant opportunity, as leveraging individual genetic information can lead to customized therapies, improving patient outcomes. However, the market faces limitations such as high development costs and lengthy regulatory approval processes. Challenges also include potential side effects and ethical concerns regarding genetic modifications.

Nevertheless, there are several potential opportunities. Companies should consider partnerships with biotech firms to combine expertise, which could fast-track innovation and product development. Investment in cutting-edge technologies like CRISPR and AI-driven drug discovery could lead to more precise treatment modalities and provide a competitive edge. Research into combination therapies that incorporate DNA repair drugs with immunotherapies or targeted therapies may expand therapeutic potential. Innovation should focus on increasing drug efficacy while minimizing adverse effects, ensuring drugs are accessible and cost-effective. The market is inherently fast-evolving, so maintaining agility is key; firms should stay updated on regulatory guidelines and emerging trends to capitalize on market shifts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA Repair Drugs Market

The DNA Repair Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of chronic and genetic diseases across the world
  • Expanding clinical trials and research initiatives to develop DNA repair drugs
  • Government initiatives to promote access to treatments for complex diseases
• Market Restraints
  • Formulation issues and complexities of DNA repair drugs
• Market Opportunities
  • Ongoing innovations to improve the efficacy and safety of DNA repair drugs
  • Consumer preference for personalized and precision strategies to manage complex diseases
• Market Challenges
  • Limitations associated with efficacy and safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the DNA Repair Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA Repair Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA Repair Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA Repair Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA Repair Drugs Market

A detailed market share analysis in the DNA Repair Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA Repair Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA Repair Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA Repair Drugs Market

A strategic analysis of the DNA Repair Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA Repair Drugs Market, highlighting leading vendors and their innovative profiles. These include Artios Pharma, AstraZeneca PLC, Aurigene Discovery Technologies, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, CanBas Co., Ltd., Clovis Oncology, Corden Pharma International GmbH, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline PLC, Hanson Wade Group, Johnson & Johnson Services, Inc., Merck KgaA, Novartis AG, Pfizer Inc., and Valerio Therapeutics.

Market Segmentation & Coverage

This research report categorizes the DNA Repair Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Alkylating Agents and Poly ADP Ribose Polymerase Inhibitors.
• Based on Form, market is studied across Capsules, Injectables, and Tablets.
• Based on Mechanism of Action, market is studied across Base Excision Repair Modulators, Double-strand Break Repair Modulators, Mismatch Repair Modulators, and Single-strand Break Repair Modulators.
• Based on Application, market is studied across Neurological Diseases and Oncology. The Oncology is further studied across Breast Cancer, Ovarian Cancer, and Prostate Cancer.
• Based on Distribution Channel, market is studied across Hospital Pharmacies and Online Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of chronic and genetic diseases across the world
    • 5.1.1.2. Expanding clinical trials and research initiatives to develop DNA repair drugs
    • 5.1.1.3. Government initiatives to promote access to treatments for complex diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Formulation issues and complexities of DNA repair drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations to improve the efficacy and safety of DNA repair drugs
    • 5.1.3.2. Consumer preference for personalized and precision strategies to manage complex diseases
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations associated with efficacy and safety concerns
• 5.2. Market Segmentation Analysis
  • 5.2.1. Form: Significant adoption of injectables for quick delivery of medication
  • 5.2.2. Application: Growing application of DNA repair drug therapy in targeted drug delivery in oncology
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. DNA Repair Drugs Market, by Drug Type

• 6.1. Introduction
• 6.2. Alkylating Agents
• 6.3. Poly ADP Ribose Polymerase Inhibitors

7. DNA Repair Drugs Market, by Form

• 7.1. Introduction
• 7.2. Capsules
• 7.3. Injectables
• 7.4. Tablets

8. DNA Repair Drugs Market, by Mechanism of Action

• 8.1. Introduction
• 8.2. Base Excision Repair Modulators
• 8.3. Double-strand Break Repair Modulators
• 8.4. Mismatch Repair Modulators
• 8.5. Single-strand Break Repair Modulators

9. DNA Repair Drugs Market, by Application

• 9.1. Introduction
• 9.2. Neurological Diseases
• 9.3. Oncology
  • 9.3.1. Breast Cancer
  • 9.3.2. Ovarian Cancer
  • 9.3.3. Prostate Cancer

10. DNA Repair Drugs Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Hospital Pharmacies
• 10.3. Online Pharmacies

11. Americas DNA Repair Drugs Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific DNA Repair Drugs Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa DNA Repair Drugs Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Merck KGaA and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Forge Alliance to Advance Cancer Treatment Innovations
  • 14.3.2. Collaboration and Innovations in Cancer Treatment by F. Hoffmann-La Roche AG and KSQ Therapeutics, Inc. in DNA Repair Drugs
  • 14.3.3. FDA Approves New Combination Therapy for Advanced Prostate Cancer Featuring Genetic Mutations
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Artios Pharma
• 2. AstraZeneca PLC
• 3. Aurigene Discovery Technologies
• 4. Bio-Rad Laboratories, Inc.
• 5. Bristol-Myers Squibb Company
• 6. CanBas Co., Ltd.
• 7. Clovis Oncology
• 8. Corden Pharma International GmbH
• 9. Eli Lilly and Company
• 10. Genentech, Inc.
• 11. GlaxoSmithKline PLC
• 12. Hanson Wade Group
• 13. Johnson & Johnson Services, Inc.
• 14. Merck KgaA
• 15. Novartis AG
• 16. Pfizer Inc.
• 17. Valerio Therapeutics